NCI Cancer Bulletin: A Trusted Source for Cancer Research News
June 7, 2005 • Volume 2 / Number 23 E-Mail This Document  |  View PDF Version  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
NCAB Approves Redesign of NCI Clinical Trials System

Director's Update
A New Era for Cancer Survivors

Spotlight
Restructuring the NCI Clinical Trials Enterprise

Cancer Research Highlights
Free NRT Program Helps New York City Smokers Quit

Improved Breast Cancer Outcomes Seen with Docetaxel Adjuvant Regimen

Study Finds Breast Cancer Risk with NSAID Use

Mouse Has p53 Tumor Suppressor Gene with On/Off Switch

Mouse Study Suggests Optimal Cells for Immunotherapy

Funding Opportunities

Featured Clinical Trial
Pilot Study of Erlotinib to Treat NSCLC

NCI to Form Translational Research Working Group

Notes
Coleman Awarded ASTRO Gold Medal

NCI Testifies on Radiation Effects from Nuclear Weapons Testing

Cancer Center Profile
Mayo Clinic Cancer Center

Bulletin Archive

Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
PDF Version  View/Print PDF
Director's Update

A New Era for Cancer Survivors

The closer we've scrutinized what it means to be a cancer survivor in the United States, the more we've learned about how remarkably complex and daunting an experience it can be. Our intensive study over the past decade has produced excellent data about the risk of second cancers and late effects of treatment, as well as cancer's impact on survivors' emotional and psychological well-being, their ability to maintain or get insurance, their function in the workplace, and even on their relationships with their families and friends.

As former ASCO President and cancer survivor Dr. David Johnson described: With this disease, there is no "Humpty Dumpty moment" during which a patient is reconstructed and simply returns to who he or she was before diagnosis.

But thanks to legions of dedicated advocates and researchers, we have made remarkable strides in elucidating the survivorship experience. And just 2 days ago, many of the more than 10 million cancer survivors in the United States celebrated National Cancer Survivors' Day, embodying all that we've learned about the travails of cancer survivors and how to offer them the individualized support they need and deserve.

Last year we saw what I believe will be a watershed event in the survivorship movement, the release of the President's Cancer Panel report on cancer survivorship. The report provided a number of important recommendations to address survivors' issues and needs. Among other things, it called for better monitoring of long-term and late effects and for oncologists to provide patients who have completed cancer therapy with a record of the treatments they received to help guide their future care by other providers.

The NCI Office of Cancer Survivorship (OCS), under the leadership of Dr. Julia Rowland and her team of proactive program staff, is shepherding the science of survivorship research. In addition to funding innovative studies, OCS is actively partnering with other organizations to use avenues like the Internet and teleconferencing to help educate survivors about the available tools to aide recovery and to make survivorship research, resources, and care more accessible.

For example, NCI, along with the Lance Armstrong Foundation, has provided funds for a telephone education workshop series produced in collaboration with several survivorship and cancer organizations and delivered by CancerCare. The last workshop had nearly 1,900 participants, including individuals from countries such as India, Germany, Kenya, and Thailand.

There is also a growing focus on helping survivors lead fuller, healthier lives by supporting appropriate follow-up care and promoting lifestyle changes such as physical activity, healthy diet, and smoking cessation that may reduce illness-related morbidity and premature mortality.

Since OCS was established in 1996, there has been a nearly five-fold increase in the number of grants it manages. Survivorship research has clearly matured over this period and study designs are increasingly sophisticated and theory-driven, often involving multidisciplinary teams striving not just to document the challenges faced by survivors, but to design and deliver effective programs to address them. In fact, almost 40 percent of currently funded OCS grants contain an intervention component.

Indeed, it is unacceptable to say that somebody who has survived cancer should "be happy just to be alive." Our goal now is clear: to help survivors not just continue to exist, but continue to live life to its fullest.

Dr. Andrew C. von Eschenbach
Director, National Cancer Institute

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov